Smallpox Vaccine (2026)
- UK Health Security Agency
- Direct award
- 1 October 2026 to 30 September 2029
Market engagement exercise to identify available smallpox vaccine products, including dose formats, unit pricing, volume-based price breaks, and minimum order quantities. Suppliers must provide technical data regarding regulatory licensing status, production capacity, lead times, shelf life, and specific cold-chain storage and handling requirements to inform future procurement strategy.
- Awarded value
- Not published
- No value in the notice
- Published
- 28 May 2026
- Contract length
- 36 months
- Ends 30 September 2029